Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:06 PM
Study NCT ID:
NCT02836379
Status:
COMPLETED
Last Update Posted:
2018-03-05
First Post:
2016-07-11
Brief Title:
Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
Sponsor:
Angelini Farmacéutica
Organization:
Angelini Farmacéutica
Study Overview
Official Title:
Quality of Life Study in Patients With Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAVIDIOR
Brief Summary:
In the context of radiotherapy control of breakthrough pain represents a special challenge Patients undergoing radiotherapy may experience different situations of pain that may be due to the need to remain immobilized during radiotherapy session the need to wear an immobilization mask head and neck cancer the odynophagia caused by mucositis defecation after the development of proctitis or sudden pain during the night causing sleep disturbances
In a survey conducted in radiation oncology services more than half of patients treated with radiotherapy experienced pain and 39 of patients reported that their pain was not treated properly This situation may increase the patients anxiety dissatisfaction with treatment affect their quality of life and can even come to refuse radiotherapy treatment
This post-authorization observational study will assess the quality of life of cancer patients with breakthrough cancer pain treated in radiotherapy services in Spanish hospitals
In a survey conducted in radiation oncology services more than half of patients treated with radiotherapy experienced pain and 39 of patients reported that their pain was not treated properly This situation may increase the patients anxiety dissatisfaction with treatment affect their quality of life and can even come to refuse radiotherapy treatment
This post-authorization observational study will assess the quality of life of cancer patients with breakthrough cancer pain treated in radiotherapy services in Spanish hospitals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None